OTTAWA, April 20 /CNW Telbec/ - Chemaphor Inc. (TSXV: CFR) today announced pursuant to the requirements of the TSX Venture Exchange, that it has granted options to purchase 58,000 common shares to members of its board of directors. The stock options were granted pursuant to the terms of Chemaphor's stock option plan and are exercisable at $0.125 per share. These grants form part of a total annual remuneration package for board members. Stock option grants are subject to necessary regulatory approvals.
Chemaphor Inc. (http://www.chemaphor.com) is a research and development company working in collaboration with strategic partners to develop its platform of carotenoid-derived oxidation compounds for commercialization at micronutrient-like levels in products for global markets, focusing primarily on animal wellness, including non-antibiotic feed additives for terrestrial and aquatic species, and food supplements for companion animals.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE CHEMAPHOR INC.
For further information: For further information: Chemaphor Inc., Dr. Graham Burton, (613) 990-0969